IART
Integra LifeSciences Holdings
13.30$
+0.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.8% | -7.1% | +13.4% | -8.9% | +16.2% | -13.6% | +8.6% | -3.3% | +8.2% | -9.9% | +6.8% | – | |
| – | +3.9% | -5.0% | +18.6% | -6.1% | +7.2% | -2.8% | +9.6% | -14.7% | +24.8% | -23.6% | +18.7% | – | |
| – | +3.7% | -8.7% | +9.2% | -11.4% | +24.4% | -21.9% | +7.7% | +8.0% | -4.8% | +4.1% | -2.0% | – | |
| – | -8.7% | +11.0% | +10.4% | -7.8% | +13.8% | -20.8% | +9.2% | -16.8% | +10.4% | -5.2% | +3.2% | – | |
| – | +0.7% | +1.6% | +17.9% | -9.4% | +0.7% | +1.7% | -0.9% | -6.0% | +0.1% | +5.3% | -3.3% | – | |
| – | -0.7% | +6.5% | +12.9% | -9.0% | +2.4% | -1.6% | +243.9% | -74.3% | -283.4% | – | +8.9% | – | |
| – | +35.6% | -89.0% | -176.4% | – | – | -143.5% | – | – | +1,280.5% | -92.8% | -51.9% | – | |
| – | +5.3% | -0.9% | +36.9% | +3.9% | -2.0% | +6.6% | +4.0% | +8.0% | +4.2% | +13.4% | -14.3% | – | |
| – | +55.1% | -118.1% | – | – | – | -233.3% | – | – | – | -155.9% | – | – | |
| – | – | -121.6% | – | – | – | -252.7% | – | – | – | -63.3% | -88.1% | – | |
| – | +1.7% | -116.5% | – | – | – | -230.1% | – | – | – | – | – | – | |
| – | +18.3% | -47.1% | +3.3% | -13.1% | +126.2% | -67.2% | -1,918.5% | – | +22.1% | -4.7% | +4.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.